Corneal Ectasia: Types, Symptoms, Treatment and Integrative Support

Corneal ectasia is a group of conditions in which the cornea, the clear dome at the front of the eye, slowly thins and bulges outward. The uneven shape causes astigmatism that keeps getting worse, so vision gradually blurs¹. Keratoconus is the most common type^1,2. The others are pellucid marginal degeneration, keratoglobus and ectasia after laser eye surgery such as LASIK^1,2. Keratoconus always affects both eyes, though one is often worse; PMD and ectasia after laser surgery can affect one eye or both, so both eyes need scans^2,3. Glasses and specialist contact lenses give useful vision for most people with keratoconus, PMD or ectasia after laser surgery; keratoglobus is harder to treat^4,5,6. Corneal cross-linking is the only treatment approved by the FDA to slow the disease, and only for keratoconus and for ectasia after refractive surgery^7,8. No treatment returns the cornea to a normal shape, so ectasia is managed rather than cured¹.

This page explains the types of corneal ectasia and how they differ, the symptoms and the emergencies that need same-day care, and how ectasia is found on a corneal scan. It then covers what treatment can do: lenses, cross-linking, ring segments and corneal transplant, and which of these the FDA has approved for which type. It ends with what is in clinical trials and where integrative care can and cannot fit alongside your cornea specialist.

Corneal ectasia at a glance

On this page

• What is corneal ectasia?
• Symptoms
• Causes and risk factors
• Diagnosis
• Treatment today
• Can it be cured?
• New treatments in clinical trials
• Living with corneal ectasia
• Where integrative care fits
• Outlook
• Frequently asked questions
• Sources

What is corneal ectasia?

The cornea is the clear front window of the eye. It does most of the focusing. In corneal ectasia, part or all of the cornea becomes thinner and weaker and starts to bulge outward. The bulge bends light unevenly, which causes irregular astigmatism, blur and distortion¹.

Experts group these conditions together as ectatic corneal diseases. They are told apart mainly by where the cornea thins and in what pattern². Whether they are truly separate diseases or different forms of one disease is still debated^9,2.

Keratoconus

Keratoconus is the most common type^1,2. The cornea thins and bulges into a cone, usually starting in the teens or twenties¹. Our keratoconus guide covers it in detail.

Pellucid marginal degeneration

In pellucid marginal degeneration (PMD), a narrow, crescent-shaped band of the lower cornea thins, about 1 to 2 millimeters from its edge, and the cornea bulges just above it^11,12. The cornea stays clear, which is what "pellucid" means¹². PMD causes a high degree of a particular kind of astigmatism^9,13.

PMD is rare; there is no reliable figure for how many people have it^10,4. It is about three times more common in men than in women⁹. It usually starts later than keratoconus, with an average age at diagnosis in the mid-to-late thirties, and it tends to progress more slowly^4,3,14. It often affects both eyes, but not always^4,3.

Keratoglobus

Keratoglobus is very rare. The whole cornea thins and bulges into a globe shape, and it is thinnest near the edge^15,2. It is usually present from birth or early childhood but can develop later^6,2. It can be linked to inherited conditions such as brittle cornea syndrome and Ehlers-Danlos syndrome, and to blue-tinged whites of the eyes (blue sclera)^6,16. Because the cornea is so thin, even a minor knock to the eye can tear it^6,16.

Ectasia after laser eye surgery

Rarely, the cornea thins and bulges months or years after LASIK, PRK or SMILE^17,1. Recent large studies found it in about 1 to 3 of every 10,000 eyes after LASIK. A review of all reported cases put it closer to 1 in 1,000, and some SMILE clinics have reported higher rates^18,17,19,20. Our page on ectasia after LASIK explains who is at risk and how it is treated.

Symptoms of corneal ectasia

Early ectasia may cause no symptoms¹. When symptoms appear, they usually come on slowly^1,10:

• vision that gets worse over months or years;
• glasses that no longer correct vision well, or a prescription that keeps changing;
• glare and halos around lights, especially at night;
• doubled or "ghost" images, or distortion.

Signs that need prompt care

Go to an emergency room right away (call 911 if you cannot get there safely) if you have keratoglobus or a very thin cornea and your eye is hit, even lightly, or you have sudden pain, sudden loss of vision or fluid leaking from the eye. The cornea may have torn^6,16. Do not press on, rub or handle the eye, and do not try to take anything out of it. Tape a clean paper cup over the eye as a shield, so that nothing touches it^21,22,23.

See your eye doctor the same day for:

• sudden clouding and a sharp drop in vision in one eye. This can be hydrops, when fluid leaks into the cornea through a tear in its inner layer^10,13;
• a red, painful eye while wearing contact lenses. Take the lenses out and call your eye doctor right away²⁴. If you have keratoglobus, even a light knock can tear the cornea, so call your eye doctor first and ask how to take the lenses out safely⁶;
• a red, painful eye or worsening vision in the days after cross-linking. Infection of the cornea can occur⁷.

What causes corneal ectasia, and who is at risk?

The causes differ by type.

• Keratoconus runs in families and is linked to eye rubbing and allergy. In a worldwide review of studies, eye rubbing roughly tripled the odds of keratoconus²⁵. These studies show a link, not proof of cause. The keratoconus guide covers this in detail.
• Pellucid marginal degeneration has no known cause. In a Japanese survey, about 1 in 5 people with it had an allergic condition³. No strong link to other diseases has been found¹⁰.
• Keratoglobus present from birth can be inherited, for example through genes that cause brittle cornea syndrome^26,16. Later-onset keratoglobus has been linked to severe eye allergy, eyelid inflammation, thyroid eye disease and heavy eye rubbing^6,2.
• Ectasia after laser eye surgery is more likely when the cornea had an abnormal shape before surgery, the cornea was thin, the person was young, the correction was large, or too little tissue was left after surgery²⁷. In some people the surgery may unmask a tendency to keratoconus that was already there¹⁷.

Rubbing your eyes can make some types of ectasia worse^1,28.

How corneal ectasia is diagnosed

Corneal ectasia is diagnosed by an ophthalmologist or optometrist with a slit-lamp examination and a corneal scan¹.

• Corneal tomography is a painless scan that maps the front and back surfaces of the cornea and its thickness. It is the main test for finding and tracking all types of ectasia^9,2.
• Corneal topography maps the front surface. A pattern called "crab claw" or "kissing doves" is typical of PMD, but keratoconus can show it too, so the thickness map is needed to tell them apart^14,29,30.
• Progression means a consistent change in at least two of these: the front curve, the back curve, the thinnest point, or vision³¹. Scans may be needed as often as every 3 to 6 months¹.

Corneal ectasia treatment today

Treatment has two aims: to give clear vision and, where the cornea is getting worse, to stop it progressing^1,9.

Glasses and contact lenses

Glasses can work in mild disease¹. As astigmatism becomes irregular, most people see better with rigid contact lenses. In PMD, 75% to 95% reached 20/40 vision or better with rigid lenses in studies, and in one large Indian series 88% of eyes were managed with glasses or contact lenses alone^9,4. Large scleral lenses vault over the cornea and can help when glasses or other lenses do not give clear vision^32,9. Lenses do not stop the disease from progressing^33,1.

In keratoglobus, even putting in or taking out a contact lens can tear the cornea, so glasses are usually the safer choice^6,16. Only wear lenses fitted by a cornea specialist who knows you have keratoglobus, and ask them to show you how to remove them safely⁶.

Corneal cross-linking

Cross-linking uses riboflavin (vitamin B2) eye drops and ultraviolet light to stiffen the cornea⁷.

• What the FDA has approved. Photrexa with the KXL system, which removes the surface layer of the cornea ("epi-off"), was approved in April 2016 for progressive keratoconus and in July 2016 for corneal ectasia after refractive surgery^34,7. Its safety and effectiveness have not been established in children under 14⁷. Epioxa, which leaves the surface layer in place ("epi-on"), was approved in October 2025 for keratoconus only, from age 13^34,8.
• Other types are off-label. Neither label covers pellucid marginal degeneration or keratoglobus^7,8. In PMD, small studies without comparison groups suggest cross-linking may help hold the cornea steady, but results vary: in one 5-year study of 40 eyes, the cornea still got steeper in 8^35,36. Treating the lower edge of the cornea also risks harming the cells that renew its surface⁹. In keratoglobus and brittle cornea syndrome, cross-linking has been described in only a few single-patient reports, so it is not known whether it is safe or helpful^37,38.
• It seems to work less well in ectasia after surgery than in keratoconus. In one study, the cornea kept getting worse within 3 years in 22% of treated ectasia eyes, against 4% of keratoconus eyes³⁹. See ectasia after LASIK for more⁴⁰.
• Side effects. Eye pain and haze in the cornea are common. In the US trials, haze was still present at 12 months in 6% of people with ectasia. Infection of the cornea can occur⁷.

Ring segments

Ring segments are small curved implants placed inside the cornea to flatten it. The FDA allows one brand, Intacs, under a humanitarian exemption, for adults 21 and older with keratoconus who can no longer see well with lenses or glasses and whose only other option is a transplant⁴¹. Use in other types of ectasia is off-label. In advanced PMD, the thinning near the edge often makes them unsafe¹⁰.

Corneal transplant

A transplant is needed when lenses no longer give useful vision or the cornea is scarred or dangerously thin^42,5.

• In PMD, the thin area is near the edge, so grafts must be large and off-center⁴³. A partial-thickness graft (DALK) gives vision similar to a full-thickness graft (PK) without the risk of rejection of the inner layer; full-thickness grafts are a last resort⁴².
• In keratoglobus, surgeons may add tissue to strengthen the whole cornea before it ruptures^44,45.

Protecting the cornea

• Stop rubbing your eyes and treat any eye allergy^1,31.
• Keratoglobus: wear protective polycarbonate glasses^16,6.
• No LASIK. People with keratoconus should not have laser vision correction^46,47. Pellucid marginal degeneration is also a recognized risk factor for ectasia after LASIK⁴⁸.

Can corneal ectasia be cured?

No treatment returns the cornea to a normal shape¹. Cross-linking aims to stop it getting worse and sometimes flattens the cornea a little⁷. Lenses or surgery restore useful vision for most people with keratoconus, PMD or ectasia after surgery^5,9. Most people need regular check-ups for many years.

New treatments for corneal ectasia in clinical trials

No company is testing a new treatment made for PMD, keratoglobus or ectasia after laser eye surgery. The two phase 3 trials of EpiSmart, a new cross-linking treatment, left out people with these conditions⁴⁹. Some US eye doctors run their own cross-linking studies that accept people with PMD or ectasia after laser surgery; none we found includes keratoglobus. In the UK, a small study is testing an implant made from pig collagen for severe ectasia after LASIK⁴⁹. Status is as of 20 October 2026.

Living with corneal ectasia

• Keep your scan appointments, because progression can be silent¹.
• Do not rub your eyes, and treat allergies^1,31.
• Follow your lens care plan, and ask about a new fitting if lenses become uncomfortable.
• If you have keratoglobus, wear protective glasses every day¹⁶.
• Tell any eye surgeon about your diagnosis before any procedure^48,50.

Where integrative care fits

Netra Eye Institute is an acupuncture and Oriental medicine practice. Nothing we offer replaces cross-linking, specialist contact lenses or corneal surgery, and corneal ectasia care stays with your cornea specialist. Our role is adjunctive: care that sits alongside your specialist's treatment, with the evidence explained before you start.

We found no clinical studies of acupuncture, Chinese herbal medicine, Ayurveda or supplements in pellucid marginal degeneration, keratoglobus or ectasia after laser eye surgery⁵¹. The part of care where integrative support may fit is the itch-and-rub cycle, because eye rubbing can make some types of ectasia worse^1,28. Acupuncture and herbs have not been studied specifically for itchy eyes or eye rubbing. Acupuncture has some evidence, modest and uncertain, for hay fever symptoms^52,53.

Evidence grades describe how sure we can be about the effect on corneal ectasia. None means no studies; low means consistent observational studies, expert agreement or weak trials. These grades are our own reading of the studies.

What working with Netra looks like. We ask first that a cornea specialist or optometrist has made the diagnosis and set a plan for scans and treatment. If your vision changes suddenly, or your eye becomes red and painful, see them first; that comes before anything we do. Then we:

• check that the basics are in place: regular corneal scans, a plan for cross-linking if your specialist recommends it, and allergy treatment;
• support your efforts to stop rubbing with habit coaching and, if you choose, acupuncture, which has not been tested for this;
• where appropriate, offer Chinese herbal medicine reviewed against your medicines;
• never put herbal washes or drops in the eye, and wait for your surgeon's approval before any treatment near the eyes after cross-linking or a transplant;
• if you have keratoglobus or a very thin cornea, not place needles or press around the eyes, because periocular acupuncture can rarely injure the eye⁵⁴;
• keep your eye doctor informed, and send you back to them quickly if your vision changes or your eye becomes red or painful.

Netra Restoration Therapy (NRT) is an adjunctive program: it is used only alongside your cornea specialist's care, never instead of it. It is not a treatment for corneal ectasia. It does not replace cross-linking, specialist lenses or corneal surgery, and it does not strengthen the cornea or reverse thinning. No clinical trial of NRT in corneal ectasia has been published.

Outlook

The outlook depends on the type.

• Keratoconus: see the keratoconus guide.
• Pellucid marginal degeneration usually progresses slowly⁴. In a Japanese survey, about half of people saw 20/20 with glasses, and only 5% saw 20/200 or worse³. It does not cause complete blindness¹².
• Keratoglobus has the most guarded outlook, because the cornea can rupture. In a series of 48 people in India, half of the children's eyes had no useful vision, more often when the whites of the eyes were blue⁶.
• Ectasia after laser eye surgery: in a US series of 74 eyes, 78% reached 20/40 or better, mostly with rigid lenses, and 8% needed a transplant⁵.

Frequently asked questions

What is the difference between corneal ectasia and keratoconus?

Corneal ectasia is the umbrella term for conditions in which the cornea thins and bulges. Keratoconus is the most common type^1,2.

Can corneal ectasia be fixed or cured?

It cannot be cured. Cross-linking aims to stop it getting worse, and lenses or a transplant restore useful vision for most people^1,7,5.

How fast does corneal ectasia progress?

It varies by type and by person. PMD usually progresses more slowly than keratoconus^14,4. Only regular corneal scans can show whether it is changing¹.

Is pellucid marginal degeneration the same as keratoconus?

They are related but differ in where the cornea thins: in PMD a narrow band near the lower edge, in keratoconus usually a cone nearer the center^9,12. A corneal thickness map tells them apart¹⁴.

Can cross-linking treat pellucid marginal degeneration?

It is sometimes used, but it is not FDA-approved for PMD, and the evidence comes from small studies, most with short follow-up^7,35,36.

What is keratoglobus, and is it dangerous?

It is a very rare condition in which the whole cornea becomes thin and globe-shaped. The cornea can rupture after a minor injury, so protective glasses are recommended^15,6,16.

Does corneal ectasia affect both eyes?

Keratoconus always does, though often one eye more than the other. PMD and ectasia after laser surgery can affect one eye or both. Have both eyes scanned^2,3.

Can I have LASIK if I have corneal ectasia?

No. LASIK and SMILE are not advised, and other laser surgery to get rid of glasses is rarely an option^48,46,55,31. In a few people with mild keratoconus, a cornea specialist may use a surface laser together with cross-linking^31,56. Ask your cornea specialist, not a LASIK clinic.

How common is ectasia after LASIK?

It is rare: about 1 to 3 in 10,000 eyes in recent large studies, and about 1 in 1,000 in a review of all reported cases^18,17. See ectasia after LASIK.

Can acupuncture or supplements help corneal ectasia?

Acupuncture, herbs and Ayurveda have not been tested in any type of corneal ectasia⁵¹. A few small supplement studies exist in keratoconus only, and none showed that a supplement stops or reverses it; see our keratoconus guide. Netra offers acupuncture only as adjunctive care alongside your cornea specialist, with the evidence explained.

Sources

1. Cleveland Clinic. Corneal Ectasia. Updated August 7, 2023. link
2. Ambrósio R Jr, et al. Multimodal diagnostics for keratoconus and ectatic corneal diseases: a paradigm shift. Eye Vis (Lond). 2023. link
3. Shimazaki J, et al. National survey of pellucid marginal corneal degeneration in Japan. Jpn J Ophthalmol. 2016. link
4. Das AV, et al. Clinical profile and demographic distribution of pellucid marginal corneal degeneration in India: A study of 559 patients. Indian J Ophthalmol. 2021. link
5. Woodward MA, et al. Visual rehabilitation and outcomes for ectasia after corneal refractive surgery. J Cataract Refract Surg. 2008. link
6. Rathi VM, et al. Keratoglobus: An experience at a tertiary eye care center in India. Indian J Ophthalmol. 2015. link
7. Glaukos (Avedro). PHOTREXA VISCOUS and PHOTREXA (riboflavin 5'-phosphate ophthalmic solution) prescribing information. Revised February 2025 (DailyMed version effective July 24, 2026). link
8. Glaukos (Avedro). EPIOXA HD and EPIOXA (riboflavin 5'-phosphate ophthalmic solution) prescribing information. October 2025. link
9. Tsatsos M, et al. Pellucid Marginal Degeneration: A Comprehensive Review of Pathophysiology, Diagnosis, and Management Strategies. J Clin Med. 2025. link
10. Vieira IV, et al. Update on pellucid marginal degeneration. Graefes Arch Clin Exp Ophthalmol. 2026. link
11. Krachmer JH. Pellucid marginal corneal degeneration. Arch Ophthalmol. 1978. link
12. Cleveland Clinic. Pellucid Marginal Degeneration. Updated March 13, 2023. link
13. Sridhar MS, et al. Pellucid marginal corneal degeneration. Ophthalmology. 2004. link
14. Martínez-Abad A, Piñero DP. Pellucid marginal degeneration: Detection, discrimination from other corneal ectatic disorders and progression. Cont Lens Anterior Eye. 2019. link
15. Wallang BS, Das S. Keratoglobus. Eye (Lond). 2013. link
16. Burkitt Wright EM, et al. Brittle cornea syndrome: recognition, molecular diagnosis and management. Orphanet J Rare Dis. 2013. link
17. Moshirfar M, et al. Ectasia After Corneal Refractive Surgery: A Systematic Review. Ophthalmol Ther. 2021. link
18. Bohac M, et al. Incidence and Clinical Characteristics of Post LASIK Ectasia: A Review of over 30,000 LASIK Cases. Semin Ophthalmol. 2018. link
19. Brar S, et al. Incidence of Ectasia After SMILE From a High-Volume Refractive Surgery Center in India. J Refract Surg. 2021. link
20. Moshirfar M, et al. Compilation of Published Cases and a New Case Report of Corneal Ectasia After Keratorefractive Lenticule Extraction. Cornea. 2026. link
21. Cesarz T, et al. When the Nail Gun Goes Wrong: A Case of Penetrating Globe Injury. Cureus. 2025. link
22. Zhou Y, et al. Open Globe Injuries: Review of Evaluation, Management, and Surgical Pearls. Clin Ophthalmol. 2022. link
23. Butterfield E, et al. Explosive Weapons Trauma Care Collective (EXTRACCT) Blast Injury Clinical Practice Guideline: Ocular Trauma. World J Surg. 2026. link
24. Centers for Disease Control and Prevention. What Causes Contact Lens-related Eye Infections. May 27, 2025. link
25. Hashemi H, et al. The prevalence and risk factors for keratoconus: a systematic review and meta-analysis. Cornea. 2020. link
26. Weiner C, et al. Association of Variants in TMEM45A With Keratoglobus. JAMA Ophthalmol. 2021. link
27. Randleman JB, et al. Risk assessment for ectasia after corneal refractive surgery. Ophthalmology. 2008. link
28. Padmanabhan P, et al. Post-LASIK keratectasia triggered by eye rubbing and treated with topography-guided ablation and collagen cross-linking--a case report. Cornea. 2012. link
29. Lee BW, et al. Ectatic disorders associated with a claw-shaped pattern on corneal topography. Am J Ophthalmol. 2007. link
30. Walker RN, et al. Scheimpflug photographic diagnosis of pellucid marginal degeneration. Cornea. 2008. link
31. Buzzonetti L, et al. Paediatric keratoconus: an ERN-EYE clinical consensus statement on diagnosis, treatment and follow-up care. Ophthalmol Ther. 2026. link
32. Kumar M, et al. The effect of scleral lenses on vision, refraction and aberrations in post-LASIK ectasia, keratoconus and pellucid marginal degeneration. Ophthalmic Physiol Opt. 2021. link
33. Bohac M, et al. Management of Post-LASIK Ectasia. Mater Sociomed. 2023. link
34. U.S. Food and Drug Administration, via openFDA. Drugs@FDA approval records for Photrexa (NDA 203324) and Epioxa (NDA 219910). Checked October 19, 2026. Photrexa · Epioxa
35. Yong JJ, Hatch KM. Corneal Cross-Linking: An Effective Treatment Option for Pellucid Marginal Degeneration. Semin Ophthalmol. 2019. link
36. Irajpour M, et al. Corneal Cross-Linking in Pellucid Marginal Degeneration: Evaluation after Five Years. J Curr Ophthalmol. 2022. link
37. Hafezi F, et al. Cross-linking treatment of ultrathin corneas: the ELZA-sub400 protocol [in German]. Ophthalmologie. 2026. link
38. Kaufmann C, et al. Corneal cross-linking for brittle cornea syndrome. Cornea. 2015. link
39. Chanbour W, et al. Corneal Cross-Linking for Keratoconus and Post-LASIK Ectasia and Failure Rate: A 3 Years Follow-Up Study. Cureus. 2021. link
40. Greenstein SA, et al. Long-Term Outcomes After Corneal Cross-linking for Progressive Keratoconus and Corneal Ectasia: A 10-Year Follow-Up of the Pivotal Study. Eye Contact Lens. 2023. link
41. U.S. Food and Drug Administration. Humanitarian Device Exemption H040002: INTACS Prescription Inserts for Keratoconus. Approved July 26, 2004. link
42. Moshirfar M, et al. Current options in the management of pellucid marginal degeneration. J Refract Surg. 2014. link
43. Varley GA, et al. The results of penetrating keratoplasty for pellucid marginal corneal degeneration. Am J Ophthalmol. 1990. link
44. Javadi MA, et al. Outcomes of epikeratoplasty for advanced keratoglobus. Cornea. 2007. link
45. Karimian F, et al. Limbal stem cell-sparing lamellar keratoplasty for the management of advanced keratoglobus. Cornea. 2014. link
46. Colin J, Velou S. Current surgical options for keratoconus. J Cataract Refract Surg. 2003. link
47. Schmitt-Bernard CF, et al. Keratectasia induced by laser in situ keratomileusis in keratoconus. J Refract Surg. 2000. link
48. Randleman JB. Post-laser in-situ keratomileusis ectasia: current understanding and future directions. Curr Opin Ophthalmol. 2006. link
49. ClinicalTrials.gov records NCT06100939 and NCT06100952 (EpiSmart phase 3), NCT07124910, NCT07135167, NCT04094090 and NCT07841470 (doctor-led cross-linking studies) and NCT04741230 (porcine collagen lenticule, UK). Checked October 20, 2026. NCT06100939 · NCT06100952 · NCT07124910 · NCT07135167 · NCT04094090 · NCT07841470 · NCT04741230
50. U.S. Food and Drug Administration. When is LASIK not for me? July 11, 2018. link
51. Netra Eye Institute. Literature searches of PubMed and Europe PMC for corneal ectasia, post-LASIK ectasia, pellucid marginal degeneration and keratoglobus with acupuncture, Chinese herbal medicine, Ayurveda, homeopathy and supplements. Run October 19, 2026. PubMed · Europe PMC
52. Brinkhaus B, et al. Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med. 2013. link
53. He M, et al. Acupuncture for allergic rhinitis: a systematic review and meta-analysis. Eur J Med Res. 2022. link
54. Lee SM, et al. Severe adverse events of periocular acupuncture: a review of cases. Korean J Ophthalmol. 2023. link
55. Moshirfar M, et al. Ectasia following small-incision lenticule extraction (SMILE): a review of the literature. Clin Ophthalmol. 2017. link
56. Ezzeldin M, et al. Excimer laser treatment combined with riboflavin ultraviolet-A (UVA) collagen crosslinking (CXL) in keratoconus: a literature review. Int Ophthalmol. 2020. link